Literature DB >> 33671182

IgLON5 Regulates the Adhesion and Differentiation of Myoblasts.

Jeong Ho Lim1, Mirza Masroor Ali Beg1, Khurshid Ahmad2, Sibhghatulla Shaikh1,2, Syed Sayeed Ahmad1,2, Hee Jin Chun1, Dukhwan Choi1, Woo-Jong Lee3, Jun-O Jin1,2, Jihoe Kim1,2, Arif Tasleem Jan4, Eun Ju Lee1,2, Inho Choi1,2.   

Abstract

IgLON5 is a cell adhesion protein belonging to the immunoglobulin superfamily and has important cellular functions. The objective of this study was to determine the role played by IgLON5 during myogenesis. We found IgLON5 expression progressively increased in C2C12 myoblasts during transition from the adhesion to differentiation stage. IgLON5 knockdown (IgLON5kd) cells exhibited reduced cell adhesion, myotube formation, and maturation and reduced expressions of different types of genes, including those coding for extracellular matrix (ECM) components (COL1a1, FMOD, DPT, THBS1), cell membrane proteins (ITM2a, CDH15), and cytoskeletal protein (WASP). Furthermore, decreased IgLON5 expression in FMODkd, DPTkd, COL1a1kd, and ITM2akd cells suggested that IgLON5 and these genes mutually control gene expression during myogenesis. IgLON5 immunoneutralization resulted in significant reduction in the protein level of myogenic markers (MYOD, MYOG, MYL2). IgLON5 expression was higher in the CTX-treated gastrocnemius mice muscles (day 7), which confirmed increase expression of IgLON5 during muscle. Collectively, these results suggest IgLON5 plays an important role in myogenesis, muscle regeneration, and that proteins in ECM and myoblast membranes form an interactive network that establishes an essential microenvironment that ensures muscle stem cell survival.

Entities:  

Keywords:  IgLON5; extracellular matrix; muscle stem (satellite) cell; myoblast; myogenesis; skeletal muscle

Year:  2021        PMID: 33671182     DOI: 10.3390/cells10020417

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  2 in total

Review 1.  Anti-IgLON5 Disease - The Current State of Knowledge and Further Perspectives.

Authors:  Natalia Madetko; Weronika Marzec; Agata Kowalska; Dominika Przewodowska; Piotr Alster; Dariusz Koziorowski
Journal:  Front Immunol       Date:  2022-03-01       Impact factor: 7.561

2.  A combined analysis of bulk and single-cell sequencing data reveals that depleted extracellular matrix and enhanced immune processes co-contribute to fluorouracil beneficial responses in gastric cancer.

Authors:  Shaowei Dong; Siyu Zhang; Pan Zhao; Guanchuan Lin; Xiaoshi Ma; Jing Xu; Hao Zhang; Jiliang Hu; Chang Zou
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.